WiseGuyReports.com adds“Blood Plasma Derivatives 2016 World Market Share,Supply,Company Profiles and Market Opportunities Research Report Forecasting to 2022”reports to its database.
Blood plasma is the liquid component of blood constituting the extracellular matrix. Blood plasma plays a crucial role in maintaining the electrolyte and osmotic balance whilst preventing infection and blood disorders in the body. It primarily consists of water along with other components such as immunoglobulin, dissolved proteins, glucose, clotting factors, electrolytes and hormones. Plasma derivatives are the concentrates of specific proteins which require pooling of plasma from large number of donors. For instance, it requires more than hundred plasma donations to produce sufficient immunoglobulin for treating an immune deficient patient for one year. This has resulted in lucrative opportunities for technological innovations to improve the productivity of plasma derived products. Rising demand for plasma derived products owing to a huge patient pool and unavailability of alternative treatments, would drive the market to the next level. For instance, in case of haemophilia, currently there is no definite cure, and the patient may require a lifelong infusion of plasma derived products. The major factors contributing in the market growth are, rising disease awareness and education, organized network of donor centres and increasing commitment to research. However, high cost of treatment and safety concerns associated with blood transfusion, are likely to restrict the growth of market.
For more information or any query mail at [email protected]
The global blood plasma derivatives market is segmented on the basis of type, application and geography. On the basis of type, the market is segmented into, Fresh Frozen Plasma (FFP), Intravenous immunoglobulin (IVIG), Albumin, Factor VIII, Factor IX and Other components. The market, on the basis of application is segmented into Hemophilia A, Hemophilia B, Von Willebrand Disease and Other Factor Deficiencies. Geographically, the market is segmented across four regions namely North America, Europe, Asia Pacific, and LAMEA.
Few strategies adopted by industry players are acquisition and geographical expansion. For instance, Grigols, market leader in plasma products, has acquired numerous companies in the past few years such as Progenika biopharma, Araclon Biotech, and Talecris Biotherapeutics. In Jan 2014, Grigols acquired the blood transfusion diagnostics unit of Novartis AG to reinforce its business. The company has also expanded its geographic presence in regions such as India, Japan, Switzerland and China. The companies profiled in the report include, Grifols, S.A., Baxter International Inc., CSL Limited, Octapharma AG, Kedrion S.p.A, LFB S.A., Bain Capital, LLC and Biotest AG.
REQUEST FOR TABLE OF CONTENTS @ https://www.wiseguyreports.com/request-toc/world-blood-plasma-derivatives-market-opportunities-and-forecasts-2014-2022
KEY MARKET BENEFITS
Comprehensive analysis of factors that drive and restrict the growth of the global blood plasma derivatives market is provided
The market estimations are made in the report by conducting high-end analysis of the key market segments for the period of 2014-2020, which would enable the stakeholders to capitalize on prevailing Market - Opportunities
An in depth analysis of key segments of the market demonstrates the types of blood plasma derivatives along with the applications in the blood plasma derivative market
SWOT analysis enables to study the internal environment of the leading companies for strategy formulation
Region-wise blood plasma derivatives market conditions are comprehensively analysed in the report
Competitive intelligence highlights the business practises followed by leading market players across the geographies
The global blood plasma derivatives market is segmented below:
Global Blood Plasma Derivatives Market - By Type
Fresh Frozen Plasma (FFP)
Intravenous immunoglobulin (IVIG)
Global Blood Plasma Derivatives Market - By Application
Von Willebrand Disease
Other Factor Deficiencies
Global Blood Plasma Derivatives Market - By Geography
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.
We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:
- Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
- Technologically sophisticated and reliable insights through well audited and veracious research methodology
- Sovereign research proceeds that present a tangible depiction of marketplace
For more information or any query mail at [email protected]
P: +44 208 133 9349
M: +1 646 845 9349